av/natco-pharma--big.svg

IN:CO:NATCOPHARMA

NATCO Pharma

  • Stock

INR

Last Close

1,357.60

25/11 09:40

Market Cap

212.46B

Beta: -

Volume Today

445.59K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
7.31B
-
8.19B
12.03%
11.25B
37.41%
20.40B
81.35%
21.57B
5.73%
20.62B
4.40%
18.88B
8.44%
16.90B
10.46%
19.05B
12.70%
27.07B
42.11%
39.99B
47.72%
cost of revenue
2.76B
-
2.83B
2.71%
3.93B
38.79%
6.94B
76.53%
5.09B
26.67%
4.62B
9.24%
5.10B
10.41%
6.08B
19.20%
6.82B
12.11%
6.27B
7.95%
14.28B
127.71%
gross profit
4.55B
-
5.35B
17.67%
7.32B
36.67%
13.46B
83.94%
16.48B
22.43%
16.00B
2.91%
13.78B
13.88%
10.82B
21.44%
12.23B
13.03%
20.80B
70.00%
25.70B
23.59%
selling and marketing expenses
261.60M
-
373.58M
42.80%
1.13B
201.61%
1.43B
27.09%
1.37B
4.40%
1.37B
0.22%
981M
28.50%
344M
64.93%
437M
27.03%
961M
119.91%
general and administrative expenses
266.44M
-
241.46M
9.37%
252.23M
4.46%
380M
50.66%
381M
0.26%
514M
34.91%
587M
14.20%
565M
3.75%
818M
44.78%
1.07B
30.68%
selling general and administrative expenses
528.04M
-
615.05M
16.48%
1.38B
124.21%
1.81B
31.40%
1.75B
3.42%
1.89B
7.77%
1.57B
16.86%
909M
42.03%
1.25B
38.06%
2.03B
61.75%
10.06B
395.47%
research and development expenses
142.85M
-
126.08M
11.74%
150.70M
19.52%
460M
205.24%
462M
0.43%
724M
56.71%
633M
12.57%
1.47B
132.70%
1.77B
20.10%
902M
49.01%
other expenses
14.15M
-
14.19M
0.33%
18.15M
27.89%
11M
39.39%
16M
45.45%
20M
25%
40M
100%
110M
175%
40M
63.64%
1.05B
2,515%
1.28B
22.47%
cost and expenses
5.80B
-
6.48B
11.67%
8.89B
37.15%
13.84B
55.80%
12.81B
7.45%
13.44B
4.89%
13.97B
3.93%
11.89B
14.84%
17.63B
48.20%
19.35B
9.80%
24.34B
25.78%
operating expenses
3.04B
-
3.65B
19.79%
4.95B
35.88%
6.90B
39.35%
7.72B
11.86%
8.82B
14.19%
8.87B
0.53%
5.81B
34.42%
10.81B
85.93%
13.08B
21.00%
10.06B
23.10%
interest expense
343.13M
-
302.93M
11.72%
212.17M
29.96%
160M
24.59%
132M
17.50%
162M
22.73%
177M
9.26%
88M
50.28%
132M
50%
145M
9.85%
192M
32.41%
ebitda
1.94B
-
2.25B
15.95%
2.89B
28.48%
7.21B
149.91%
9.70B
34.46%
9.10B
6.11%
6.75B
25.81%
6.85B
1.42%
3.34B
51.24%
10.40B
211.44%
17.51B
68.37%
operating income
1.51B
-
1.71B
13.40%
2.36B
38.37%
6.55B
177.42%
8.76B
33.56%
7.18B
17.99%
4.91B
31.59%
5.01B
2.00%
2.20B
56.11%
8.76B
298.54%
15.65B
78.53%
depreciation and amortization
304.43M
-
472.66M
55.26%
509.53M
7.80%
544M
6.77%
662M
21.69%
810M
22.36%
998M
23.21%
1.17B
17.13%
1.43B
21.98%
1.64B
14.87%
167.90K
99.99%
total other income expenses net
-216.09M
-
-365.52M
69.15%
-296.64M
18.85%
-311M
4.84%
117M
137.62%
1.07B
811.97%
775M
27.37%
786M
1.42%
-177M
122.52%
-145M
18.08%
1.09B
851.03%
income before tax
1.29B
-
1.34B
4.06%
2.07B
53.95%
6.24B
202.19%
8.87B
42.09%
8.25B
7.04%
5.69B
31.04%
5.80B
1.92%
2.02B
65.11%
8.62B
326.26%
16.73B
94.16%
income tax expense
308.70M
-
39.50M
87.20%
527.98M
1,236.60%
1.40B
164.22%
1.92B
37.63%
1.82B
5.05%
1.11B
39.33%
1.37B
24.05%
322M
76.53%
1.47B
355.28%
2.85B
94.54%
net income
1.03B
-
1.35B
31.03%
1.55B
15.27%
4.86B
213.19%
6.96B
43.25%
6.44B
7.44%
4.61B
28.49%
4.41B
4.32%
1.70B
61.44%
7.15B
320.76%
13.88B
94.09%
weighted average shs out
159.73M
-
165.60M
3.68%
170.45M
2.93%
174.23M
2.22%
177.31M
1.77%
184.21M
3.89%
181.93M
1.23%
182.16M
0.12%
182.40M
0.13%
182.57M
0.09%
179.11M
1.89%
weighted average shs out dil
159.73M
-
165.60M
3.68%
170.96M
3.24%
174.41M
2.02%
177.94M
2.03%
184.78M
3.84%
182.46M
1.26%
182.49M
0.02%
182.40M
0.05%
182.57M
0.09%
179.11M
1.89%
eps
6.43
-
8.13
26.44%
9.14
12.42%
27.89
205.14%
39.26
40.77%
34.98
10.90%
25.33
27.59%
24.20
4.46%
9.32
61.49%
39.18
320.39%
77.34
97.40%
epsdiluted
6.43
-
8.13
26.44%
9.11
12.05%
27.87
205.93%
39.13
40.40%
34.87
10.89%
25.26
27.56%
24.16
4.35%
9.32
61.42%
39.18
320.39%
77.34
97.40%

All numbers in INR (except ratios and percentages)